ZA974946B - Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases. - Google Patents

Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases.

Info

Publication number
ZA974946B
ZA974946B ZA9704946A ZA974946A ZA974946B ZA 974946 B ZA974946 B ZA 974946B ZA 9704946 A ZA9704946 A ZA 9704946A ZA 974946 A ZA974946 A ZA 974946A ZA 974946 B ZA974946 B ZA 974946B
Authority
ZA
South Africa
Prior art keywords
carnitines
inflammatory bowel
chronic inflammatory
alkanoyl
bowel diseases
Prior art date
Application number
ZA9704946A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ZA974946B publication Critical patent/ZA974946B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA9704946A 1996-06-06 1997-06-05 Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases. ZA974946B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000396A IT1284661B1 (it) 1996-06-06 1996-06-06 Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali.

Publications (1)

Publication Number Publication Date
ZA974946B true ZA974946B (en) 1997-12-18

Family

ID=11404269

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704946A ZA974946B (en) 1996-06-06 1997-06-05 Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases.

Country Status (14)

Country Link
US (2) US6013670A (de)
EP (1) EP0811376B1 (de)
JP (1) JP4171085B2 (de)
KR (1) KR100450293B1 (de)
AT (1) ATE226069T1 (de)
CA (1) CA2206995C (de)
DE (1) DE69716341T2 (de)
DK (1) DK0811376T3 (de)
ES (1) ES2185897T3 (de)
IT (1) IT1284661B1 (de)
MX (1) MX9704150A (de)
PT (1) PT811376E (de)
TW (1) TW585763B (de)
ZA (1) ZA974946B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348495B1 (en) * 1996-06-06 2002-02-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for treating celiac disease
EP0972516A1 (de) * 1998-06-25 2000-01-19 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. L-Carnitin ersetzende Zusammensetzung ohne gastrointestinale Nebenwirkungen
WO2001066108A1 (en) * 2000-03-07 2001-09-13 Mucosal Therapeutics Inhibition of ceramide for the prevention and treatment of oral mucositis induced by antineoplastic drugs or radiation
JP4104834B2 (ja) * 2001-04-13 2008-06-18 株式会社東芝 Ｍｉｓ型電界効果トランジスタの製造方法
ITRM20040168A1 (it) * 2004-04-01 2004-07-01 Sigma Tau Ind Farmaceuti Composizione a rilascio modificato ph dipendente.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN100421648C (zh) * 2006-08-15 2008-10-01 苏州市立医院 氢化考的松灌肠剂及其制备方法
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
CN119097619A (zh) * 2024-09-05 2024-12-10 中国人民解放军海军军医大学 乙酰基肉碱在制备预防和/或治疗炎症性肠病的药物中的应用
CN119033751B (zh) * 2024-09-05 2025-10-31 中国人民解放军海军军医大学 棕榈酰基肉碱在制备预防和/或治疗炎症性肠病的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
IT1181682B (it) * 1985-06-11 1987-09-30 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto
IT1258370B (it) * 1992-03-02 1996-02-26 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil l-carnitine dotati di attivita' miorilassante selettiva sull'apparato gastro-intestinale e composizioni farmaceutiche che li contengono.
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi

Also Published As

Publication number Publication date
DK0811376T3 (da) 2003-03-10
ITRM960396A0 (it) 1996-06-06
DE69716341D1 (de) 2002-11-21
JPH1059845A (ja) 1998-03-03
MX9704150A (es) 1997-12-31
PT811376E (pt) 2003-03-31
EP0811376B1 (de) 2002-10-16
ATE226069T1 (de) 2002-11-15
CA2206995A1 (en) 1997-12-06
IT1284661B1 (it) 1998-05-21
KR980000444A (ko) 1998-03-30
KR100450293B1 (ko) 2004-11-20
CA2206995C (en) 2007-10-30
ES2185897T3 (es) 2003-05-01
TW585763B (en) 2004-05-01
EP0811376A1 (de) 1997-12-10
US6143785A (en) 2000-11-07
JP4171085B2 (ja) 2008-10-22
US6013670A (en) 2000-01-11
DE69716341T2 (de) 2003-06-05
ITRM960396A1 (it) 1997-12-06

Similar Documents

Publication Publication Date Title
AU696678B2 (en) Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
UA32429C2 (uk) Засіб для лікування нетримання сечі
HU9302384D0 (en) 2,4-diamino-quinazoline derivatives and medical preparatives containing them
ZA908777B (en) Oral composition for the treatment of inflammatory bowel diseases
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
ZA974946B (en) Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases.
PL332643A1 (en) 1h-pyrido-[3,4-b]-indolo-4-carboxyamidic derivatives, their production and application in medical treatment
IL133913A0 (en) Treatment of inflammatory disorders of the bowel and urinary bladder
ZA952519B (en) Therapeutic use of hemoglobin in the treatment of blood vessel blockage
IL98075A0 (en) Azabenzimidazoles in the treatment of asthma,arthritis and related diseases
GB9102796D0 (en) Water treatment agent
AU2548795A (en) Antithrombin agents in treatment of asthma
NZ324615A (en) Method for treating autism using olanzapine
EP0733365A3 (de) Verwendung von Benzochinolin-3-one zur Behandlung und Vorbeugung von Prostatkarzinom
GB9024860D0 (en) Treatment of dispersions
ZA947912B (en) Treatment of medical disorders associated with free radical formation
EP0408525A3 (en) Use in therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e)azepine-6,11-dione and derivatives as drugs for use in the treatment of urinary incontinence
陈传荣 DOUBLE BALLOON ANGIOPLASTY FOR TREATING RESTENOTIC VEIN GRAFT
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
GB9408916D0 (en) Treatment of sewage
HU9600216D0 (en) Agent for water treatment and process for producing it
GB2279070B (en) Process for the treatment of sewage
IL108464A0 (en) Methods of treatment using ciliary neurotrophic factor
GB9212748D0 (en) Water treatment agent